These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4173226)

  • 21. Dup 753 prevents the development of puromycin aminonucleoside-induced nephrosis.
    Yayama K; Kawao M; Tujii H; Itoh N; Okamoto H
    Eur J Pharmacol; 1993 May; 236(2):337-8. PubMed ID: 8319760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine protease and antiprotease activity in experimental aminonucleoside nephrotoxicity.
    Mayer M; Yedgar S; Joffe M; Shafrir E
    Nephron; 1981; 29(5-6):223-8. PubMed ID: 7033808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of albumin administration on L-tryptophan levels in the serum and tissues of rats with puromycin aminonucleoside-induced nephrosis.
    Sasaki E; Ohta Y; Ishiguro I
    Adv Exp Med Biol; 1999; 467():341-6. PubMed ID: 10721075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Passive dual immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta maximally ameliorates acute aminonucleoside nephrosis.
    Martín A; Molina A; Bricio T; Mampaso F
    Clin Exp Immunol; 1995 Feb; 99(2):283-8. PubMed ID: 7851023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats.
    Olson JL; Rennke HG; Venkatachalam MA
    Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats.
    Couser WG; Jermanovich NB; Belok S; Stilmant MM; Hoyer JR
    J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOST-TUMOUR RELATIONSHIP. XII. PROTEINS OF NORMAL RAT SERUM.
    DOLEZALOVA V; BRADA Z; KOCENT A
    Neoplasma; 1964; 11():151-63. PubMed ID: 14160695
    [No Abstract]   [Full Text] [Related]  

  • 28. Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats.
    Takashima K; Nishiyama C; Arisaka N; Takahashi T; Souma S; Tsuda M; Hayashi M; Kasahara H; Kodama H; Tamura T; Murakami M; Kuroda J; Sato F
    Arzneimittelforschung; 2009; 59(2):79-85. PubMed ID: 19338138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury.
    Diamond JR; Pesek I; Ruggieri S; Karnovsky MJ
    Am J Physiol; 1989 Nov; 257(5 Pt 2):F798-807. PubMed ID: 2589483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
    Kokui K; Yoshikawa N; Nakamura H; Itoh H
    J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
    Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of CD54, CD18, MHC class II molecules, and proliferating cell nuclear antigen in acute puromycin aminonucleoside nephrosis.
    Fernandez L; Romero M; Rincón J; Mosquera J
    Nephron Exp Nephrol; 2003; 94(2):e55-65. PubMed ID: 12845231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An ultrastructural study of the glomerular slit diaphragm in aminonucleoside nephrosis.
    Ryan GB; Rodewald R; Karnovsky MJ
    Lab Invest; 1975 Nov; 33(5):461-8. PubMed ID: 1186127
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased apoptosis in acute puromycin aminonucleoside nephrosis.
    Fernandez L; Romero M; Soto H; Mosquera J
    Exp Nephrol; 2001; 9(2):99-108. PubMed ID: 11150858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key molecular events in puromycin aminonucleoside nephrosis rats.
    Guan N; Ding J; Deng J; Zhang J; Yang J
    Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats.
    Someya T; Kaneko K; Yamada T; Yamashiro Y
    Pediatr Nephrol; 2005 Oct; 20(10):1430-4. PubMed ID: 16079985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin.
    Abboud HE; Ou SL; Velosa JA; Shah SV; Dousa TP
    J Clin Invest; 1982 Feb; 69(2):327-36. PubMed ID: 7056851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of zelandopam, a dopamine D1-like receptor agonist, in puromycin aminonucleoside nephrosis rats.
    Yatsu T; Aoki M; Tanaka A
    Eur J Pharmacol; 2005 Mar; 510(1-2):121-6. PubMed ID: 15740732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.